MyeloMATCH MSRP (Acute Myeloid Leukemia & Myelodysplastic Syndrome) - Clinical Trial
¿Cuál es el Propósito de este estudio?
We are doing this study to see if blood and bone marrow samples can be tested in a timely manner that allows for the detection of certain markers that could guide cancer treatment.
¿Cuál es la Condición que se está estudiando?
Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
¿Quién puede participar en el Estudio?
Adults ages 18+ who:
- Are suspected to have previously untreated AML or MDS (paarticipants with AML cannot have a history of previously treated myeloproliferative neoplasms)
- Have not received prior anti-cancer therapy for AML or MDS (previous erythroid stimulating agent is not considered prior therapy for the purposes of eligibility)
For more information about this study, please contact the study team at nick.jeffries@duke.edu.
Grupo etario
Adultos
¿Qué Implica?
If you choose to join this study, you will have blood draws and bone marrow samples taken for testing.
Detalles del Estudio
Título Completo
MYELOMATCH, Master Screening and Reassessment Protocol (MSRP) for Tier Advancement in the NCI MyeloMATCH Clinical Trials
Investigador Principal
Especialista en oncología hematológica
Número de Protocolo
IRB:
PRO00116097
NCT:
NCT05564390
ClinicalTrials.gov
View on ClinicalTrials.gov
Estado de inscripción
Abierto para inscripción